Primum non nocere: safety in clinical trials for IPF

Respirology. 2011 Jul;16(5):723-4. doi: 10.1111/j.1440-1843.2011.01971.x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Disease Progression*
  • Everolimus
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Lung / pathology*
  • Male
  • Sirolimus / adverse effects
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Everolimus
  • Sirolimus